Protocols
Prodermic 585 is a gentle multi-agent retinol system formulated for sensitive skin anti-aging and retinoid introduction. Combines Retinol 7% with Phytic Acid 10% for antioxidant protection, Lactic Acid 10% for hydrating exfoliation, and Salicylic Acid 3% for pore-level penetration, plus supporting Arbutin, Arginine, and Kojic Acid to block pigment production.
Prodermic 585 is a gentle multi-agent retinol system formulated for sensitive skin anti-aging and retinoid introduction.Combines Retinol 7% with Phytic Acid 10% for antioxidant protection, Lactic Acid 10% for hydrating exfoliation, and Salicylic Acid 3% for pore-level penetration, plus supporting Arbutin, Arginine, and Kojic Acid to block pigment production. Over 50% total active concentration across 7 agents — achieving broad anti-aging through multi-pathway coverage at gentle individual doses.The ideal retinoid entry point for retinol-naive or sensitive patients. ~24 sessions per 30ml jar.
RET-7MA Complex — A 7-agent retinoid-led system with phytic acid antioxidant protection, dual pigment-blocking, and multi-acid resurfacing at gentle concentrations.Retinol 7% drives skin renewal while Phytic Acid 10% provides antioxidant protection, Lactic Acid 10% delivers hydrating exfoliation, and Salicylic Acid 3% ensures pore-level penetration. Supporting agents Arbutin, Arginine, and Kojic Acid add pigment-blocking and blood-flow support.Comprehensive sensitive-skin anti-aging through multiple gentle pathways rather than one aggressive approach.
Recommended sequence for prodermic 585. Frequency: As prescribed by professional.
Patients wanting retinoid benefits but intolerant to 580s high concentrations, retinol-naive patients, anti-aging + mild brightening
If desired results are not achieved, it does not indicate the peel is ineffective—it may simply mean that the skin has a higher tolerance to the current formulation. In such cases, consider transitioning to a stronger peel, applying multiple coats, or increasing the application time in subsequent sessions.
